149 related articles for article (PubMed ID: 22336201)
1. Relationship between chromatin structure and sensitivity to molecularly targeted auger electron radiation therapy.
Terry SY; Vallis KA
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1298-305. PubMed ID: 22336201
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor inhibition modulates the nuclear localization and cytotoxicity of the Auger electron emitting radiopharmaceutical 111In-DTPA human epidermal growth factor.
Bailey KE; Costantini DL; Cai Z; Scollard DA; Chen Z; Reilly RM; Vallis KA
J Nucl Med; 2007 Sep; 48(9):1562-70. PubMed ID: 17704253
[TBL] [Abstract][Full Text] [Related]
3. ErbB-2 blockade and prenyltransferase inhibition alter epidermal growth factor and epidermal growth factor receptor trafficking and enhance (111)In-DTPA-hEGF Auger electron radiation therapy.
Cornelissen B; Darbar S; Hernandez R; Kersemans V; Tullis I; Barber PR; Smart S; Vojnovic B; Reilly R; Vallis KA
J Nucl Med; 2011 May; 52(5):776-83. PubMed ID: 21498540
[TBL] [Abstract][Full Text] [Related]
4. Relationship between induction of phosphorylated H2AX and survival in breast cancer cells exposed to 111In-DTPA-hEGF.
Cai Z; Chen Z; Bailey KE; Scollard DA; Reilly RM; Vallis KA
J Nucl Med; 2008 Aug; 49(8):1353-61. PubMed ID: 18632822
[TBL] [Abstract][Full Text] [Related]
5. Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical.
Cornelissen B; Darbar S; Kersemans V; Allen D; Falzone N; Barbeau J; Smart S; Vallis KA
Nucl Med Biol; 2012 Nov; 39(8):1142-51. PubMed ID: 22819196
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.
Chen P; Cameron R; Wang J; Vallis KA; Reilly RM
J Nucl Med; 2003 Sep; 44(9):1469-78. PubMed ID: 12960194
[TBL] [Abstract][Full Text] [Related]
7. 111In-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR.
Reilly RM; Kiarash R; Cameron RG; Porlier N; Sandhu J; Hill RP; Vallis K; Hendler A; Gariépy J
J Nucl Med; 2000 Mar; 41(3):429-38. PubMed ID: 10716315
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional block copolymer micelles for the delivery of 111In to EGFR-positive breast cancer cells for targeted Auger electron radiotherapy.
Fonge H; Lee H; Reilly RM; Allen C
Mol Pharm; 2010 Feb; 7(1):177-86. PubMed ID: 19924993
[TBL] [Abstract][Full Text] [Related]
9. Effect of the EGFR density of breast cancer cells on nuclear importation, in vitro cytotoxicity, and tumor and normal-tissue uptake of [111In]DTPA-hEGF.
Hu M; Scollard D; Chan C; Chen P; Vallis K; Reilly RM
Nucl Med Biol; 2007 Nov; 34(8):887-96. PubMed ID: 17998090
[TBL] [Abstract][Full Text] [Related]
10. Preclinical pharmacokinetic, biodistribution, toxicology, and dosimetry studies of 111In-DTPA-human epidermal growth factor: an auger electron-emitting radiotherapeutic agent for epidermal growth factor receptor-positive breast cancer.
Reilly RM; Chen P; Wang J; Scollard D; Cameron R; Vallis KA
J Nucl Med; 2006 Jun; 47(6):1023-31. PubMed ID: 16741313
[TBL] [Abstract][Full Text] [Related]
11. Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, enhances radiosensitivity and suppresses lung metastasis in breast cancer in vitro and in vivo.
Chiu HW; Yeh YL; Wang YC; Huang WJ; Chen YA; Chiou YS; Ho SY; Lin P; Wang YJ
PLoS One; 2013; 8(10):e76340. PubMed ID: 24130769
[TBL] [Abstract][Full Text] [Related]
12. A comparison of non-biologically active truncated EGF (EGFt) and full-length hEGF for delivery of Auger electron-emitting 111In to EGFR-positive breast cancer cells and tumor xenografts in athymic mice.
Panosa C; Fonge H; Ferrer-Batallé M; Menéndez JA; Massaguer A; De Llorens R; Reilly RM
Nucl Med Biol; 2015 Dec; 42(12):931-8. PubMed ID: 26385534
[TBL] [Abstract][Full Text] [Related]
13. Suberoylanilide hydroxamic acid affects γH2AX expression in osteosarcoma, atypical teratoid rhabdoid tumor and normal tissue cell lines after irradiation.
Blattmann C; Oertel S; Thiemann M; Weber KJ; Schmezer P; Zelezny O; Lopez Perez R; Kulozik AE; Debus J; Ehemann V
Strahlenther Onkol; 2012 Feb; 188(2):168-76. PubMed ID: 22249335
[TBL] [Abstract][Full Text] [Related]
14. Computational analysis of the number, area and density of gamma-H2AX foci in breast cancer cells exposed to (111)In-DTPA-hEGF or gamma-rays using Image-J software.
Cai Z; Vallis KA; Reilly RM
Int J Radiat Biol; 2009 Mar; 85(3):262-71. PubMed ID: 19296344
[TBL] [Abstract][Full Text] [Related]
15. Radiosensitization of glioblastoma cells using a histone deacetylase inhibitor (SAHA) comparing carbon ions with X-rays.
Barazzuol L; Jeynes JC; Merchant MJ; Wéra AC; Barry MA; Kirkby KJ; Suzuki M
Int J Radiat Biol; 2015 Jan; 91(1):90-8. PubMed ID: 25040548
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate, paclitaxel, and doxorubicin radiosensitize HER2-amplified human breast cancer cells to the Auger electron-emitting radiotherapeutic agent (111)In-NLS-trastuzumab.
Costantini DL; Villani DF; Vallis KA; Reilly RM
J Nucl Med; 2010 Mar; 51(3):477-83. PubMed ID: 20150272
[TBL] [Abstract][Full Text] [Related]
17. Alterations in histone acetylation following exposure to
Tian XL; Lu X; Feng JB; Cai TJ; Li S; Tian M; Liu QJ
Radiat Environ Biophys; 2018 Aug; 57(3):215-222. PubMed ID: 29774413
[TBL] [Abstract][Full Text] [Related]
18. A comparison of EGF and MAb 528 labeled with 111In for imaging human breast cancer.
Reilly RM; Kiarash R; Sandhu J; Lee YW; Cameron RG; Hendler A; Vallis K; Gariépy J
J Nucl Med; 2000 May; 41(5):903-11. PubMed ID: 10809207
[TBL] [Abstract][Full Text] [Related]
19. Comparative antiproliferative effects of (111)In-DTPA-hEGF, chemotherapeutic agents and gamma-radiation on EGFR-positive breast cancer cells.
Chen P; Mrkobrada M; Vallis KA; Cameron R; Sandhu J; Hendler A; Reilly RM
Nucl Med Biol; 2002 Aug; 29(6):693-9. PubMed ID: 12234595
[TBL] [Abstract][Full Text] [Related]
20. Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy.
Chen MY; Liao WS; Lu Z; Bornmann WG; Hennessey V; Washington MN; Rosner GL; Yu Y; Ahmed AA; Bast RC
Cancer; 2011 Oct; 117(19):4424-38. PubMed ID: 21491416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]